QA: Globestar Therapeutics Corp in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001502152_2019_Globestar_Therapeutics_Corp.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001502152, Globestar Therapeutics Corp

  xvar xval
0 AssetsCurrent 111,807
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,294
3 remainder_Assets 11,644
4 LiabilitiesCurrent 995,476
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 207
8 SellingGeneralAndAdministrativeExpense 371,750
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 263,718
11 remainder_Revenues 5,779
12 remainder_NetIncome -154,643
13 remainder_ComprehensiveNetIncome 1,940
  yvar yval
0 Assets 124,745
1 Liabilities 995,476
2 Expenses 635,675
3 Revenues 5,779
4 StockholdersEquity -870,731
5 NetIncome -784,539
6 ComprehensiveNetIncome -783,569
7 BaseVar 959,129
8 EconomicCapitalRatiobeforeLimitedLiability -4.79
9 EconomicCapitalRatio 0.225

Edgar->Model Mapping

Feature Distribution

Change over Time